Anemia Clinical Trials

Find Anemia Clinical Trials Near You

Ultrasound Use Compared With Standard Care for Diagnosis of Blood Loss After Cesarean Delivery: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other, Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Women who delivered by a cesarean section.

• Age over 18.

• Fluent in Hebrew or Arabic.

• Signed informed consent form.

Locations
Other Locations
Israel
Holy family hospital
RECRUITING
Nazareth
Contact Information
Primary
Raed Sa, MD
r.salim@hfhosp.org
+972544986960
Backup
Bassam Abboud, MD
Dr.bassamabb@gmail.com
+972526792999
Time Frame
Start Date: 2025-05-08
Estimated Completion Date: 2027-06-01
Participants
Target number of participants: 276
Treatments
Active_comparator: Ultrasound group
Group 1: patients will undergo an abdominal and transvaginal ultrasound examination within 24 - 48 hours post-surgery.
Active_comparator: Standard care group
Group 2: Candidates will be managed according to the standard care, i.e., without a routine postpartum ultrasound.
Related Therapeutic Areas
Sponsors
Leads: Holy Family Hospital, Nazareth, Israel

This content was sourced from clinicaltrials.gov